ViiV Healthcare is a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV
It is an independent pharmaceutical company established in 2009 by combining the power and expertise in the management of HIV from both GSK and Pfizer. Following a long-term collaboration on the joint development of several novel integrase inhibitors, ViiV was joined by Shionogi in 2012.
The company is 100% dedicated to HIV and aims to take a deeper and broader interest in HIV/AIDS than any company has done before. ViiV's focus is to deliver effective and new HIV medicines and to provide support for the communities affected by the epidemic.
ViiV Healthcare in Australia
In Australia, ViiV Healthcare has been involved in supporting research through investigator initiated and pivotal clinical studies, and is actively involved in expanding local access to treatment through compassionate supply. ViIV also actively supports Australian community initiatives in HIV prevention, treatment and awareness.
Find out more about ViiV from the following sources: